Where Could Canopy Growth (TSX:WEED) Be in 3 Years?

The future of Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) has become more uncertain after losing $1 billion in three months. Investors would like to see how the weed company rises from this fiasco before investing in the stock again.

| More on:
question marks written reminders tickets

Image source: Getty Images

Is Canopy Growth (TSX:WEED)(NYSE:CGC) heading into freefall? The stock fell by 14.4% to $36.41 after the largest cannabis producer reported $1.28 billion losses in the first quarter of fiscal 2020 ended June 30, 2019. It was a far cry from the $90 million loss in Q1 of fiscal 2019.

Likewise, Canopy’s operating loss rose by 300.65% to $123 million in the June quarter compared with the same quarter a year ago. The latest earnings result is a sign that Canopy would not be profitable anytime soon.

The midterm future is very foggy for the once much-admired Canadian cannabis company. Canopy Growth’s board of directors, of which the majority are Constellation Brands-appointed, is now running the show.

Fallout  

If you were to predict the future of Canopy Growth three years down the road, you’d have to dig deep to find a silver lining. The company’s founder and former CEO Bruce Linton is out of the picture. But acting Chief Executive Mark Zekulin said they’re working behind the scenes.

The colossal loss doesn’t comprise cash but a mere accounting entry. Constellation Brands, Canopy’s business partner and significant shareholder, is delaying in order to exercise its warrants to buy shares of Canopy. The American beverage giant has so far shelled out $5.3 billion, but could buy more shares in 2020.

Canopy Growth still has $3.1 billion cash in its war chest as of June 30, so there is no urgency on Constellation Brands’ part to exercise the warrants. However, it’s not clear whether the Corona beer maker intends to acquire a majority stake in Canopy.

Canopy Growth’s sold $90.5 million worth of recreational and medical cannabis during the quarter; however, it fell short of the $109 million consensus estimate. In fairness, the average selling price for recreational marijuana declined from the March quarter. Sales of recreational marijuana accounted for 86% of the total.

The company is excited about the prospects of edibles and cannabis-infused beverages in Canada. Come December this year, Canopy Growth expects to see a rise in cannabis revenues and hopefully profit.

No more grand plans

Bruce Linton had ambitious dreams for Canopy Growth, and Constellation Brands bought into the idea by investing a fortune. Unfortunately, the excessive spending and mounting losses were too much to bear.

Canopy’s interim head Zekulin told investors that the multi-year period of intensive spending and building is almost over. The focus now is to evolve from builders to operators over the rest of this fiscal year.

It appears that the way to profitability is through the value-added products with a high margin. Management believes that the company would be a revenue machine in the edibles and cannabis-infused beverage market.

I can only say where Canopy Growth would be in three years after the next two quarterly earnings. With the cloud of uncertainty over the company, WEED will hit its 52-week low of $34.36 next then and sink deeper. The sell signals are strong.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Jars of marijuana
Cannabis Stocks

Is Tilray Stock a Buy in the New Bullish Market?

Canadian cannabis producer Tilray has underperformed the broader markets in the last five years due to its weak fundamentals.

Read more »

Bad apple with good apples
Cannabis Stocks

1 TSX Stock I Wouldn’t Touch With a 10-Foot Pole

Down 99% from all-time highs, Aurora Cannabis stock remains a high-risk bet due to its weak fundamentals and risky liquidity…

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »